The innate immune response in leprosy

Current Opinion in Immunology

Volumn 22, Issue 1, 2010, Pages 48-54

  Modlin, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD209 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DOWN REGULATION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INNATE IMMUNITY; LEPROSY; LIPID OXIDATION; MACROPHAGE; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; REGULATORY MECHANISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; LEPROSY; MYCOBACTERIUM LEPRAEMURIUM; RECEPTORS, PATTERN RECOGNITION;

EID: 77249110401     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2009.12.001     Document Type: Review

References (94)

1. Bloom B.R. Learning from leprosy: a perspective on immunology and the third world. J Immunol 137 (1986) i-i10
2. Ridley D.S., and Jopling W.H. Classification of leprosy according to immunity. A five-group system. Int J Lepr 34 (1966) 255-273
3. Modlin R.L., Hofman F.M., Taylor C.R., and Rea T.H. T lymphocyte subsets in the skin lesions of patients with leprosy. J Am Acad Dermatol 8 (1983) 182-189
4. Cooper C.L., Mueller C., Sinchaisri T.-A., Pirmez C., Chan J., Kaplan G., Young S.M.M., Weissman I.L., Bloom B.R., Rea T.H., and Modlin R.L. Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med 169 (1989) 1565-1581
5. Yamamura M., Uyemura K., Deans R.J., Weinberg K., Rea T.H., Bloom B.R., and Modlin R.L. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254 (1991) 277-279
6. Yamamura M., Wang X.-H., Ohmen J.D., Uyemura K., Rea T.H., Bloom B.R., and Modlin R.L. Cytokine patterns of immunologically mediated tissue damage. J Immunol 149 (1992) 1470-1475
7. Metschnikoff E. Ueber eine Sprosspilzkrankheit der Daphnien. Beitrag zur Lehre uber den Kampf der Phagocyten gegen Krankheitserrenger. Archiv f.pathologische Anatomie und Physiologie und f.klinische Medicin 96 (1884) 177-195. The most classic work.
8. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285 (1999) 732-736
9. Aliprantis A.O., Yang R.-B., Mark M.R., Suggett S., Devaux B., Radolf J.D., Klimpel G.R., Godowski P., and Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285 (1999) 736-739
10. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., and Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169 (2002) 10-14
11. Means T.K., Wang S., Lien E., Yoshimura A., Golenbock D.T., and Fenton M.J. Human Toll-Like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163 (1999) 3920-3927
12. Bowdish D.M., Sakamoto K., Kim M.J., Kroos M., Mukhopadhyay S., Leifer C.A., Tryggvason K., Gordon S., and Russell D.G. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 5 (2009) e1000474. An elegant study showing a novel mechanism by which a pathogen-associated molecular pattern is recognized by a pattern recognition receptor.
13. Reiling N., Holscher C., Fehrenbach A., Kroger S., Kirschning C.J., Goyert S., and Ehlers S. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 169 (2002) 3480-3484
14. Drennan M.B., Nicolle D., Quesniaux V.J., Jacobs M., Allie N., Mpagi J., Fremond C., Wagner H., Kirschning C., and Ryffel B. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol 164 (2004) 49-57
15. Bafica A., Scanga C.A., Feng C.G., Leifer C., Cheever A., and Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 202 (2005) 1715-1724
16. Krutzik S.R., Ochoa M.T., Sieling P.A., Uematsu S., Ng Y.W., Legaspi A., Liu P.T., Cole S.T., Godowski P.J., Maeda Y., et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med 9 (2003) 525-532
17. Yamashita Y., Maeda Y., Takeshita F., Brennan P.J., and Makino M. Role of the polypeptide region of a 33 kDa mycobacterial lipoprotein for efficient IL-12 production. Cell Immunol 229 (2004) 13-20
18. Maeda Y., Mukai T., Spencer J., and Makino M. Identification of an immunomodulating agent from Mycobacterium leprae. Infect Immun 73 (2005) 2744-2750
19. Krutzik S.R., Tan B., Li H., Ochoa M.T., Liu P.T., Sharfstein S.E., Graeber T.G., Sieling P.A., Liu Y.J., Rea T.H., et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med 11 (2005) 653-660
20. Bleharski J.R., Li H., Meinken C., Graeber T.G., Ochoa M.T., Yamamura M., Burdick A., Sarno E.N., Wagner M., Rollinghoff M., et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 301 (2003) 1527-1530
21. Cruz D., Watson A.D., Miller C.S., Montoya D., Ochoa M.T., Sieling P.A., Gutierrez M.A., Navab M., Reddy S.T., Witztum J.L., et al. Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest 118 (2008) 2917-2928. This study provides new information on foam cells in leprosy.
22. Suzuki K., Takeshita F., Nakata N., Ishii N., and Makino M. Localization of CORO1A in the macrophages containing Mycobacterium leprae. Acta Histochem Cytochem 39 (2006) 107-112
23. Tanigawa K., Suzuki K., Kimura H., Takeshita F., Wu H., Akama T., Kawashima A., and Ishii N. Tryptophan aspartate-containing coat protein (CORO1A) suppresses Toll-like receptor signalling in Mycobacterium leprae infection. Clin Exp Immunol 156 (2009) 495-501. A key study on the phagolysosome and its effect on TLR signaling.
24. Kang T.J., and Chae G.T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 31 (2001) 53-58
25. Kang T.J., Lee S.B., and Chae G.T. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 20 (2002) 56-62
26. Bochud P.Y., Hawn T.R., and Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 170 (2003) 3451-3454
27. Schroder N.W., Hermann C., Hamann L., Gobel U.B., Hartung T., and Schumann R.R. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med 81 (2003) 368-372
28. Kang T.J., Yeum C.E., Kim B.C., You E.Y., and Chae G.T. Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation. Immunology 112 (2004) 674-680
29. Malhotra D., Relhan V., Reddy B.S., and Bamezai R. TLR2 Arg677Trp polymorphism in leprosy: revisited. Hum Genet 116 (2005) 413-415
30. Johnson C.M., Lyle E.A., Omueti K.O., Stepensky V.A., Yegin O., Alpsoy E., Hamann L., Schumann R.R., and Tapping R.I. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 178 (2007) 7520-7524. A key study on the role of a TLR1 SNP in leprosy.
31. Misch E.A., Macdonald M., Ranjit C., Sapkota B.R., Wells R.D., Siddiqui M.R., Kaplan G., and Hawn T.R. Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl Trop Dis 2 (2008) e231. An outstanding genetic study on a TLR1 polymorphism in leprosy.
32. Omueti K.O., Mazur D.J., Thompson K.S., Lyle E.A., and Tapping R.I. The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J Immunol 178 (2007) 6387-6394
33. Schuring R.P., Hamann L., Faber W.R., Pahan D., Richardus J.H., Schumann R.R., and Oskam L. Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J Infect Dis 199 (2009) 1816-1819
34. Oliveira R.B., Ochoa M.T., Sieling P.A., Rea T.H., Rambukkana A., Sarno E.N., and Modlin R.L. Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy. Infect Immun 71 (2003) 1427-1433
35. Means T.K., Wang S., Lien E., Yoshimura A., Golenbock D.T., and Fenton M.J. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163 (1999) 3920-3927
36. Bulut Y., Michelsen K.S., Hayrapetian L., Naiki Y., Spallek R., Singh M., and Arditi M. Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals. J Biol Chem 280 (2005) 20961-20967
37. Gao B., and Tsan M.F. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem 278 (2003) 174-179
38. Marincek B.C., Kuhnle M.C., Srokowski C., Schild H., Hammerling G., and Momburg F. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion. Mol Immunol 46 (2008) 181-191
39. Bochud P.Y., Sinsimer D., Aderem A., Siddiqui M.R., Saunderson P., Britton S., Abraham I., Tadesse A.A., Janer M., Hawn T.R., and Kaplan G. Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy. Eur J Clin Microbiol Infect Dis 28 (2009) 1055-1065. The key study on TLR4 polymorphisms in leprosy.
40. Hamann L., Kumpf O., Schuring R.P., Alpsoy E., Bedu-Addo G., Bienzle U., Oskam L., Mockenhaupt F.P., and Schumann R.R. Low frequency of the TIRAP S180L polymorphism in Africa, and its potential role in malaria, sepsis, and leprosy. BMC Med Genet 10 (2009) 65
41. Davila S., Hibberd M.L., Hari D.R., Wong H.E., Sahiratmadja E., Bonnard C., Alisjahbana B., Szeszko J.S., Balabanova Y., Drobniewski F., et al. Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet 4 (2008) e1000218. A thorough analysis of TLR polymorphisms in tuberculosis.
42. Yang Y., Yin C., Pandey A., Abbott D., Sassetti C., and Kelliher M.A. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J Biol Chem 282 (2007) 36223-36229
43. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., and Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278 (2003) 8869-8872
44. Delbridge L.M., and O'Riordan M.X. Innate recognition of intracellular bacteria. Curr Opin Immunol 19 (2007) 10-16
45. Gandotra S., Jang S., Murray P.J., Salgame P., and Ehrt S. Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis. Infect Immun 75 (2007) 5127-5134
46. Divangahi M., Mostowy S., Coulombe F., Kozak R., Guillot L., Veyrier F., Kobayashi K.S., Flavell R.A., Gros P., and Behr M.A. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol 181 (2008) 7157-7165
47. Austin C.M., Ma X., and Graviss E.A. Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African Americans. J Infect Dis 197 (2008) 1713-1716
48. Ferwerda G., Girardin S.E., Kullberg B.J., Le B.L., de Jong D.J., Langenberg D.M., van C.R., Adema G.J., Ottenhoff T.H., Van der Meer J.W., and Netea M.G. NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog 1 (2005) 279-285
49. Leber J.H., Crimmins G.T., Raghavan S., Meyer-Morse N.P., Cox J.S., and Portnoy D.A. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog 4 (2008) e6
50. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M.T., Engele M., Sieling P.A., Barnes P.F., Rollinghoff M., Bolcskei P.L., Wagner M., et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291 (2001) 1544-1547
51. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., Tavera-Mendoza L., Lin R., Hanrahan J.W., Mader S., and White J.H. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173 (2004) 2909-2912
52. Martineau A.R., Wilkinson K.A., Newton S.M., Floto R.A., Norman A.W., Skolimowska K., Davidson R.N., Sorensen O.E., Kampmann B., Griffiths C.J., and Wilkinson R.J. IFN-{gamma}- and TNF-independent vitamin D-inducible human suppression of Mycobacteria: the role of cathelicidin LL-37. J Immunol 178 (2007) 7190-7198. A key study on the role of cathelicidin in mycobacterial infection.
53. Liu P.T., Stenger S., Tang D.H., and Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 179 (2007) 2060-2063
54. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006) 1770-1773
55. Krutzik S.R., Hewison M., Liu P.T., Robles J.A., Stenger S., Adams J.S., and Modlin R.L. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 181 (2008) 7115-7120
56. Liu P.T., Schenk M., Walker V.P., Dempsey P.W., Kanchanapoomi M., Wheelwright M., Vazirnia A., Zhang X., Steinmeyer A., Zugel U., et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS ONE 4 (2009) e5810. This study shows that multiple antimicrobial peptides are required for host defense against mycobacterial infection.
57. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., and Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996) 973-983
58. Roy S., Frodsham A., Saha B., Hazra S.K., Mascie-Taylor C.G., and Hill A.V. Association of vitamin D receptor genotype with leprosy type. J Infect Dis 179 (1999) 187-191
59. Goulart L.R., Ferreira F.R., and Goulart I.M. Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy. FEMS Immunol Med Microbiol 48 (2006) 91-98
60. Fitness J., Floyd S., Warndorff D.K., Sichali L., Mwaungulu L., Crampin A.C., Fine P.E., and Hill A.V. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg 71 (2004) 330-340
61. Montoya D., Cruz D., Teles R.M., Lee D.J., Ochoa M.T., Krutzik S.R., Chun R., Schenk M., Zhang X., Ferguson B.G., et al. Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe 6 (2009) 343-353. This study correlates in vitro function of macrophages with phenotype in leprosy lesions.
62. Prado-Montes de O.E., Velarde-Felix J.S., Rios-Tostado J.J., Picos-Cardenas V.J., and Figuera L.E. SNP 668C (-44) alters a NF-kappaB1 putative binding site in non-coding strand of human beta-defensin 1 (DEFB1) and is associated with lepromatous leprosy. Infect Genet Evol 9 (2009) 617-625
63. Virchow R. Die krankhaften Geschwülste (1863), August Hirschwald, Berlin
64. Sakurai I., and Skinsnes O.K. Lipids in leprosy. 2. Histochemistry of lipids in human leprosy. Int J Lepr Other Mycobact Dis 38 (1970) 389-403
65. Navab M., Ananthramaiah G.M., Reddy S.T., Van Lenten B.J., Ansell B.J., Fonarow G.C., Vahabzadeh K., Hama S., Hough G., Kamranpour N., et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 45 (2004) 993-1007
66. Ridley M.J., Ridley D.S., De Beer F.C., and Pepys M.B. C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy. Clin Exp Immunol 56 (1984) 545-552
67. Gunn FD. Tuberculosis. In: Anderson W.A.D. (Ed). Pathology. edn 4 (1961), C.V. Mosby Company, St. Louis 243-263
68. Osler W. Tuberculosis. In: Osler W. (Ed). The Principles and Practice of Medicine (1892), D. Appleton and Company, New York 184-255
69. Florey H. Tuberculosis. General Pathology based on Lectures delivered at the Sir William Dunn School of Pathology (1958), University of Oxford: W.B. Saunders, Philadelphia and London 829-870
70. Ridley D.S., and Ridley M.J. Rationale for the histological spectrum of tuberculosis. A basis for classification. Pathology 19 (1987) 186-192
71. Cardona P.J., Llatjos R., Gordillo S., Diaz J., Ojanguren I., Ariza A., and Ausina V. Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis. Scand J Immunol 52 (2000) 156-163
72. Hernandez-Pando R., Pavon L., Arriaga K., Orozco H., Madrid-Marina V., and Rook G. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect Immun 65 (1997) 3317-3327
73. Kondo E., and Kanai K. Further studies on the increase in cholesterol ester content of the lungs of tuberculous mice. Jpn J Med Sci Biol 27 (1974) 59-65
74. Kondo E., and Kanai K. Accumulation of cholesterol esters in macrophages incubated with mycobacteria in vitro. Jpn J Med Sci Biol 29 (1976) 123-137
75. Korf J., Stoltz A., Verschoor J., De Baetselier P., and Grooten J. The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses. Eur J Immunol 35 (2005) 890-900
76. D'Avila H., Melo R.C., Parreira G.G., Werneck-Barroso E., Castro-Faria-Neto H.C., and Bozza P.T. Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J Immunol 176 (2006) 3087-3097
77. Almeida P.E., Silva A.R., Maya-Monteiro C.M., Torocsik D., D'Avila H., Dezso B., Magalhaes K.G., Castro-Faria-Neto H.C., Nagy L., and Bozza P.T. Mycobacterium bovis bacillus Calmette-Guerin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis. J Immunol 183 (2009) 1337-1345
78. Tanigawa K., Suzuki K., Nakamura K., Akama T., Kawashima A., Wu H., Hayashi M., Takahashi S., Ikuyama S., Ito T., and Ishii N. Expression of adipose differentiation-related protein (ADRP) and perilipin in macrophages infected with Mycobacterium leprae. FEMS Microbiol Lett 289 (2008) 72-79. A superb immunohistologic study on lipid bodies in leprosy.
79. Tailleux L., Schwartz O., Herrmann J.L., Pivert E., Jackson M., Amara A., Legres L., Dreher D., Nicod L.P., Gluckman J.C., et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 197 (2003) 121-127
80. Barreiro L.B., Quach H., Krahenbuhl J., Khaliq S., Mohyuddin A., Mehdi S.Q., Gicquel B., Neyrolles O., and Quintana-Murci L. DC-SIGN interacts with Mycobacterium leprae but sequence variation in this lectin is not associated with leprosy in the Pakistani population. Hum Immunol 67 (2006) 102-107
81. Jullien D., Sieling P.A., Uyemura K., Mar N.D., Rea T.H., and Modlin R.L. IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol 158 (1997) 800-806
82. Santos A.R., Suffys P.N., Vanderborght P.R., Moraes M.O., Vieira L.M., Cabello P.H., Bakker A.M., Matos H.J., Huizinga T.W., Ottenhoff T.H., et al. Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis 186 (2002) 1687-1691
83. Pereira A.C., Brito-de-Souza V.N., Cardoso C.C., as-Baptista I.M., Parelli F.P., Venturini J., Villani-Moreno F.R., Pacheco A.G., and Moraes M.O. Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. Genes Immun 10 (2009) 174-180. This is a through genetic and immunologic analysis of the IL-10 SNP in leprosy.
84. Malhotra D., Darvishi K., Sood S., Sharma S., Grover C., Relhan V., Reddy B.S., and Bamezai R.N. IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy. Hum Genet 118 (2005) 295-300
85. Moraes M.O., Pacheco A.G., Schonkeren J.J., Vanderborght P.R., Nery J.A., Santos A.R., Moraes M.E., Moraes J.R., Ottenhoff T.H., Sampaio E.P., et al. Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy. Genes Immun 5 (2004) 592-595
86. Franceschi D.S., Mazini P.S., Rudnick C.C., Sell A.M., Tsuneto L.T., Ribas M.L., Peixoto P.R., and Visentainer J.E. Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. Int J Infect Dis 13 (2009) 493-498
87. Martin-Fontecha A., Sebastiani S., Hopken U.E., Uguccioni M., Lipp M., Lanzavecchia A., and Sallusto F. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 198 (2003) 615-621
88. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
89. Sieling P.A., Jullien D., Dahlem M., Tedder T.F., Rea T.H., Modlin R.L., and Porcelli S.A. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J Immunol 162 (1999) 1851-1858
90. Simoes Quaresma J.A., de Oliveira M.F., Ribeiro Guimaraes A.C., de Brito E.B., de Brito R.B., Pagliari C., de Brito A.C., Xavier M.B., and Seixas Duarte M.I. CD1a and factor XIIIa immunohistochemistry in leprosy: a possible role of dendritic cells in the pathogenesis of Mycobacterium leprae infection. Am J Dermatopathol 31 (2009) 527-531
91. Miranda A., Amadeu T.P., Schueler G., Alvarenga F.B., Duppre N., Ferreira H., Nery J.A., and Sarno E.N. Increased Langerhans cell accumulation after mycobacterial stimuli. Histopathology 51 (2007) 649-656
92. Lee D.J., Sieling P.A., Ochoa M.T., Krutzik S.R., Guo B., Hernandez M., Rea T.H., Cheng G., Colonna M., and Modlin R.L. LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol 179 (2007) 8128-8136
93. Santos D.O., Castro H.C., Bourguignon S.C., Bastos O.M., Rodrigues C.R., Van H.H., Nery J.A., and Miranda A. Expression of B7-1 costimulatory molecules in patients with multibacillary leprosy and reactional states. Clin Exp Dermatol 32 (2007) 75-80
94. Murray R.A., Siddiqui M.R., Mendillo M., Krahenbuhl J., and Kaplan G. Mycobacterium leprae inhibits dendritic cell activation and maturation. J Immunol 178 (2007) 338-344. An important study of DC function in leprosy.